Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00373542
Status:
COMPLETED
Last Update Posted:
2016-10-28
First Post:
2006-09-07
Brief Title:
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A 12-Week Multi-Center Double-Blind Placebo-Controlled Parallel Group Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome RLS in RLS Patients With Sleep Disturbance and Periodic Limb Movements PLM During Sleep
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CR-RLS
Brief Summary:
The purpose of this study is to assess the efficacy and safety of ropinirole CR-RLS in the treatment of patients with Restless Legs Syndrome and associated sleep disturbance and period limb movements during sleep
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None